Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 Oct 8;19(12):3055–3086. doi: 10.1158/1055-9965.EPI-10-0877

Table 6.

XRCC3 Thr241Met and Smoking: Overall and by study characteristics

Ever-never * Current-Not current PY ,§

N Q
p-
value
ORz
(95% CI)
Ratio of ORs
(95% CI)
N Q
p-
value
ORz
(95% CI)
Ratio of ORs
(95% CI)
N Q
p-
value
ORz
(95% CI)
Ratio of
ORs
(95% CI)
Overall

9 0.5 1.0 (0.9, 1.2) 7 0.7 0.9 (0.8, 1.1) 4 0.7 0.8 (0.6, 1.2)

By Study Characteristic

Continent
    North America 2 0.1 0.9 (0.6, 1.3) Ref 1 --- 0.8 (0.5, 1.2) na 2 0.3 0.7 (0.4, 1.3) Ref
    Europe 7 0.7 1.1 (0.9, 1.3) 1.1 (0.8, 1.7) 5 0.9 0.9 (0.7, 1.1) 2 0.6 0.9 (0.6, 1.4) 1.2 (0.6, 2.5)
    Asia 0 1 --- 2.0 (0.6, 6.6) 0
Ethnicity/nationality

    Single-ethnicity studies ** 3 0.7 0.8 (0.6, 1.1) Ref 3 0.3 0.8 (0.6, 1.1) Ref 2 0.9 1.0 (0.6, 1.7) na
    Multi-ethnic studies †† 2 0.2 1.0 (0.7, 1.3) 1.2 (0.8, 1.9) 1 --- 1.0 (0.7, 1.5) 1.2 (0.7, 2) 1 --- 0.6 (0.3, 1.2)
    Unknown ethnicity 4 0.9 1.2 (1.0, 1.5) 1.5 (1.0, 2.2) 3 0.7 0.9 (0.7, 1.3) 1.1 (0.7, 1.7) 1 --- 0.8 (0.4, 1.4)
    White >=99% ‡‡ 3 0.7 0.8 (0.6, 1.1) Ref 2 0.9 0.8 (0.6, 1.1) Ref 2 0.9 1.0 (0.6, 1.7) na
    Han >=99% 0 1 --- 2.0 (0.6, 6.6) 0

HWE p-value
    Continuous (single ethnicity) 3 0.7 0.8 (0.6, 1.1) 1.0 (0.3, 3.4) 3 0.3 0.8 (0.6, 1.1) 0.4 (0.1, 1.6) 2 0.9 1.0 (0.6, 1.7)
    HWE p <0.05 0 1 --- 2.0 (0.6, 6.6) na 0 na
    HWE p <0.10 0 na 1 --- 2.0 (0.6, 6.6) na 0 na
    HWE p >=0.10 9 0.5 1.0 (0.9, 1.2) 6 0.9 0.9 (0.7, 1.1) 4 0.7 0.8 (0.6, 1.2)
Age

    Age non-missing 9 0.5 1.0 (0.9, 1.2) 1.0 (1.0, 1.0) 7 0.7 0.9 (0.8, 1.1) 0.9 (0.8, 1.1) 4 0.7 0.8 (0.6, 1.2) 0.9 (0.8, 1.1)
    <= 47.9y §§ 1 --- na 2 0.6 0.8 (0.6, 1.1) Ref 0 na
    > 47.9 y 8 0.4 1.0 (0.9, 1.2) 5 0.6 1.0 (0.8, 1.2) 1.2 (0.8, 1.9) 4 0.7 0.8 (0.6, 1.2)
    <=59y *** 5 0.3 1 (0.8, 1.2) Ref 6 0.9 0.9 (0.7, 1.1) na 1 --- 1.1 (0.4, 2.7) na
    >59y 4 0.7 1.1 (0.9, 1.5) 1.2 (0.8, 1.6) 1 --- 2.0 (0.6, 6.6) 3 0.5 0.8 (0.5, 1.1)
    At or below median 5 0.3 1.0 (0.8, 1.2) Ref 4 0.8 0.8 (0.7, 1.1) Ref 3 0.8 0.9 (0.6, 1.4) na
    Above median 4 0.7 1.1 (0.9, 1.5) 1.2 (0.8, 1.6) 3 0.5 1.0 (0.8, 1.4) 1.2 (0.8, 1.8) 1 --- 0.6 (0.3, 1.2)
Gender

    Percent male, mixed gender only 6 0.3 1 (0.9, 1.3) 1.1 (0.1, 12.6) 4 0.5 1.0 (0.8, 1.3) 0.1 (0, 3.4)
    All female 0 0 0
    Mixed gender 6 0.3 1.0 (0.9, 1.3) Ref 4 0.5 1.0 (0.8, 1.3) Ref 3 0.6 0.8 (0.5, 1.1) na
    All male 3 0.8 1.0 (0.8, 1.4) 1.0 (0.7, 1.4) 3 0.8 0.8 (0.6, 1.1) 0.9 (0.6, 1.3) 1 --- 1.0 (0.5, 1.9)
Study outcome
    Lung cancer 0 0 1 --- 1.1 (0.4, 2.7) na
    Other cancer 5 0.4 1 (0.8, 1.2) Ref 4 0.5 1.0 (0.7, 1.2) Ref 3 0.5 0.8 (0.5, 1.1)
    Non-cancer disease 0 0 0
    Non-disease 4 0.7 1.2 (0.9, 1.6) 1.2 (0.8, 1.7) 3 0.7 0.9 (0.6, 1.2) 0.9 (0.6, 1.3) 0
    Lung cancer 0 0 na 1 --- 1.1 (0.4, 2.7) na
    All other 9 0.5 1.0 (0.9, 1.2) na 6 0.7 0.9 (0.8, 1.1) 3 0.5 0.8 (0.5, 1.1)

MAF
    MAF non-missing 9 0.5 1.0 (0.9, 1.2) 0.9 (0, 235.8) 7 0.7 0.9 (0.8, 1.1) 0.2 (0, 4.6) 4 0.7 0.8 (0.6, 1.2) 0 (0, 45050)
MAF (cutpoints assigned by median across SNP)
    0.01–0.37 5 0.3 1.0 (0.8, 1.3) Ref 2 0.1 0.9 (0.6, 1.4) Ref 4 0.7 0.8 (0.6, 1.2) na
    >0.37–0.50 4 0.5 1.0 (0.8, 1.3) 1.0 (0.7, 1.4) 5 0.9 0.9 (0.7, 1.1) 1.0 (0.6, 1.7) 0
MAF-assigned ethnicity
    White 7 0.5 1.1 (0.9, 1.3) Ref 5 0.9 0.9 (0.7, 1.1) na 3 0.8 0.9 (0.6, 1.4) na
    Han 0 1 --- 2.0 (0.6, 6.6) 0
    Multi-ethnic studies 2 0.2 1.0 (0.7, 1.3) 0.9 (0.7, 1.3) 1 --- 1.0 (0.7, 1.5) 1 --- 0.6 (0.3, 1.2)
Smoking prevalence 13

    Continuous 9 0.5 1.0 (0.9, 1.2) 0.1 (0, 1.8) 7 0.7 0.9 (0.8, 1.1) 0.5 (0.1, 3.1) 4 0.7 0.8 (0.6, 1.2) 2.4 (0.1, 56.6)
    >0–0.507 0 na 6 0.7 0.9 (0.8, 1.2) na 2 0.5 0.7 (0.4, 1.1) na
    >0.507–1 9 0.5 1.0 (0.9, 1.2) 1 --- 0.8 (0.6, 1.2) 2 0.9 1.0 (0.6, 1.7)

Abbreviations: CI=Confidence interval, na=not applicable, HWE = Hardy Weinberg equilibrium, PY=pack-years, ORz=control-only genotype-smoking odds ratio,), N=number of studies, Ref=referent, Q=Cochran’s test of homogeneity, SNP=single nucleotide polymorphism, Arg=Arginine, Gln=Glutamine, Trp=Tryptophan, His=Histidine, Met=methionine, Asp=Aspartic acid, Asn=Asparagine

*

OR=Unadjusted odds ratio for XRCC3 Thr241Met: Thr/Thr (ref) vs. any Met, never smoking (ref) vs. ever smoking, fixed effects

OR=Unadjusted odds ratio for XRCC3 Thr241Met: Thr/Thr (ref) vs. any Met, not current smoker (ref) vs. current smoker, fixed effects

OR=Unadjusted odds ratio for XRCC3 Thr241Met: Thr/Thr (ref) vs. any Met, lightest non-zero smokers (ref) vs. heaviest smokers; stratified random effects

§

PY contrast is between lightest non-zero category of pack-years (ref) vs. heaviest category of PY

Ratio of Odds Ratios: Compares odds ratio in given study characteristic stratum to the odds ratio in the designated reference stratum for that study characteristic by meta-regression

**

Studies w 99%–100% of 1 ethnicity are classified as single-ethnicity

††

Only includes studies with explicitly stated ethnic makeup

‡‡

White = Caucasian, white or non-Hispanic white; African American = African American or black; Han = Han, Han Chinese or ethnic Chinese

§§

Median of studies included in XRCC1 751 current/not current smoker analyses.

□□

Categories based on thirds from studies included in XRCC1 399 PY analyses (<=59y, >59y–63y, >63y)

***

Median of all studies w age info (all SNPs) w age info [range:23.6–69y, mean: 56.7y SD: 9.8y]

†††

Median proportion male in all studies (all SNPs, all smoking exposures): 0.69

‡‡‡

Smoking prevalence is contrast-specific (defined as "ever", "current" or "heavier PY" as appropriate)